Please login to the form below

Not currently logged in
Email:
Password:

Ibuprofen could reduce Parkinson's risk

OTC painkillers such as ibuprofen may reduce the risk of developing Parkinson's disease, according to new research.

OTC painkillers such as ibuprofen may reduce the risk of developing Parkinson's disease, according to new research.

Regular use of OTC NSAIDs was associated with a 60 per cent reduction in the risk of developing Parkinson's disease, compared with occasional or non-use.

The study compared the use of aspirin and other NSAIDs in 579 men and women, half of whom had Parkinson's disease. Regular NSAID use was defined as taking two or more tablets a week for at least one month. Regular use of aspirin was associated with a 40 per cent reduction in risk, but only among women.

"Our findings suggest NSAIDs are protective against Parkinson's disease, with a particularly strong effect among regular users of non-aspirin NSAIDs, especially those who reported two or more years of use," commented study author Dr Anelika Wahner of the UCLA School of Public Health in Los Angeles.

The results are published in full in the 6 November 2007 issue of Neurology, the medical journal of the American Academy of Neurology.

30th September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics